| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
44,360,000 |
| Market
Cap: |
55.01(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.9693 - $2.87 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 4.5 |
| Insider 3/6 Months : 5.1 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Immunic is a clinical-stage biopharmaceutical company. Co. is pursuing three development programs. These include the vidofludimus calcium (IMU-838) program, which is focused on the development of oral formulations of a small molecule inhibitor of the enzyme dihydroorotate dehydrogenase; the IMU-935 program, which is focused on an inverse agonist of retinoic acid receptor-related orphan nuclear receptor gamma truncated, an immune cell-specific isoform of retinoic acid receptor-related orphan nuclear receptor gamma; and the IMU-856 program, which involves the development of a drug targeting the restoration of intestinal barrier function and regeneration of bowel epithelium.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
14,000 |
14,000 |
122,500 |
| Total Buy Value |
$0 |
$18,333 |
$18,333 |
$174,157 |
| Total People Bought |
0 |
1 |
1 |
3 |
| Total Buy Transactions |
0 |
1 |
1 |
8 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Winters Terence E. |
Co-Chairman and CEO |
• • – |
2014-12-29 |
5 |
GD |
$0.00 |
$0 |
D/D |
3,240 |
182,136 |
|
- |
|
| Winters Terence E. |
Co-Chairman and CEO |
• • – |
2014-12-02 |
4 |
A |
$0.00 |
$0 |
D/D |
934 |
185,376 |
|
- |
|
| Winters Terence E. |
Co-Chairman and CEO |
• • – |
2014-10-10 |
4 |
B |
$14.81 |
$20,203 |
D/D |
1,360 |
184,442 |
2.81 |
- |
|
| Nash Duane |
See Remarks |
• – – |
2014-10-08 |
4 |
B |
$17.50 |
$1,750 |
D/D |
100 |
9,324 |
2.66 |
- |
|
| Bienaime Jean Jacques |
Director |
– • – |
2014-10-08 |
4 |
B |
$17.50 |
$75,005 |
D/D |
4,286 |
25,119 |
2.39 |
- |
|
| Halperin Errol R. |
Director |
– • – |
2014-10-08 |
4 |
B |
$17.50 |
$29,173 |
I/I |
1,667 |
10,000 |
2.1 |
- |
|
| Halperin Errol R. |
Director |
– • – |
2014-10-08 |
4 |
B |
$17.50 |
$66,658 |
D/D |
3,809 |
89,417 |
2.39 |
- |
|
| Godshall Douglas Evan |
Director |
– • – |
2014-10-08 |
4 |
B |
$17.50 |
$49,998 |
D/D |
2,857 |
69,375 |
2.39 |
- |
|
| Sears Lowell |
Director |
– • – |
2014-10-08 |
4 |
B |
$17.50 |
$25,008 |
D/D |
1,429 |
58,572 |
2.39 |
- |
|
| Satter Muneer A |
Director |
– • • |
2014-10-08 |
4 |
B |
$17.50 |
$1,300,005 |
I/I |
74,286 |
6,732,277 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2014-06-03 |
4 |
B |
$13.61 |
$92,456 |
I/I |
6,600 |
6,657,985 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2014-06-02 |
4 |
B |
$12.45 |
$98,355 |
I/I |
7,900 |
6,651,385 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2014-04-23 |
4 |
B |
$12.00 |
$4,331,592 |
I/I |
360,966 |
6,643,485 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2014-04-23 |
4 |
A |
$0.00 |
$0 |
I/I |
6,140,402 |
6,282,519 |
|
- |
|
| Sears Lowell |
Director |
– • – |
2014-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
44,643 |
57,143 |
|
- |
|
| Sears Lowell |
Director |
– • – |
2014-04-23 |
4 |
B |
$12.00 |
$150,000 |
D/D |
12,500 |
12,500 |
2.39 |
- |
|
| Halperin Errol R. |
Director |
– • – |
2014-04-23 |
4 |
A |
$0.00 |
$0 |
I/I |
39,417 |
45,608 |
|
- |
|
| Halperin Errol R. |
Director |
– • – |
2014-04-23 |
4 |
B |
$12.00 |
$174,288 |
I/I |
14,524 |
6,191 |
2.1 |
- |
|
| Millis J. Michael |
Director |
– • – |
2014-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
17,680 |
|
- |
|
| Croxford Philip M |
Director |
– • – |
2014-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,250 |
25,091 |
|
- |
|
| Croxford Philip M |
Director |
– • – |
2014-04-23 |
4 |
B |
$12.00 |
$18,000 |
D/D |
1,500 |
17,841 |
2.39 |
- |
|
| Godshall Douglas Evan |
Director |
– • – |
2014-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
54,018 |
66,518 |
|
- |
|
| Godshall Douglas Evan |
Director |
– • – |
2014-04-23 |
4 |
B |
$12.00 |
$150,000 |
D/D |
12,500 |
12,500 |
2.39 |
- |
|
| Steer Randolph C |
Director |
– • – |
2014-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
1,549 |
|
- |
|
| Bienaime Jean Jacques |
Director |
– • – |
2014-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
20,833 |
|
- |
|
113 Records found
|
|
Page 4 of 5 |
|
|
0.02 (1.64%) 
